Superficial Femoral Artery Stenosis Clinical Trial
Official title:
The Pilot Clinical Trial Comparing the Efficacy of Single-stage Multilevel Revascularization of the Iliac-femoral-popliteal Segment Using the FULL METALL JACKET Technology in Comparison With the Hybrid Revascularization Procedure
Hypothesis: "Total" endovascular revascularization of a multistory lesion of the
iliac-femoral-popliteal segment is safer and a better quality of life is achieved in
comparison with hybrid intervention.
The lack of damage to the skin avoids complications in the postoperative and remote periods
of observation, thereby improving the quality of life
Mortality from cardiovascular disease occupies a leading position worldwide. Patients with
atherosclerotic lesions of the peripheral arteries account for 20% of the total number of
patients with cardiovascular diseases. Special attention should be paid to patients with
multilevel lesions artery since the maximum reduction in blood flow leads to the development
of critical limb ischemia (CLI) and a high risk of limb loss. Almost 25% of patients with CLI
require multistory revascularization of the arteries of the lower extremities. In this group
of patients, proximal revascularization of the only iliac segment is usually the initial
approach, but in some cases leads to disappointing relief of symptoms due to concomitant
severe lesions of the infra-anginal arteries. Whereas the combined implementation of
femoral-popliteal bypass surgery or endovascular revascularization of SFA can increase the
likelihood of ulcer healing and avoid multi-stage surgical interventions. In turn, an
adequate inflow to the revascularized segment is necessary for its long-term functioning.
Femoral-popliteal bypass surgery is still the procedure of choice for long occlusions of the
superficial femoral artery TASC C, D. The "total" endovascular correction (full metal jacket)
may become an alternative to hybrid technology since allows for less traumatic and fully
revascularization of the wall occlusal lesions of SFA. The salvation of the limb and the
achievement of compensation for the clinic of chronic lower limb ischemia in patients with
multi-vessel atherosclerotic lesions of the arteries of the lower extremities is possible
using both hybrid procedures and endovascular reconstruction. The main goal of stenting the
iliac arteries during hybrid procedures is not only to restore blood flow in the common and
deep femoral arteries but also to support the long-term functioning of the femoral-popliteal
shunt or stent in SFA.
Similar analogues of the comparative study of the two methods of revascularization in the
world literature the investigators have not seen.
In the first group, stenting of the iliac artery under x-ray control with the bypass of the
femoral-popliteal segment above the gap of the knee joint is performed. The first stage is
performed femoral-popliteal bypass surgery above the fissure of the knee joint according to
conventional technology. Conduit is at the discretion of the operating surgeon.
Intraoperatively bolus is administered heparin 5000 IU. The second step is the puncture of
the selected CFA with a retrograde installation of the introducer sheath. The iliac segment
is recanalized with angioplasty and stent implantation in the affected area. In the
postoperative period, clexane is administered at a prophylactic dosage of 3 days and
cardiomagnyl at a dosage of 75 mg per day. Next, the patient takes dual antiplatelet therapy
cardiomagnyl 75 mg + clopidogrel 75 mg for 6 months.
In the second group, stenting of the iliac artery and recanalization SFA with angioplasty and
stenting under X-ray control is performed. The first step is the puncture contralateral CFA
with a retrograde installation of the introducer. Intraoperatively bolus is administered
heparin 5000 IU. A conductor is placed in the contralateral iliac artery along the conductor.
A stent is implanted in the iliac artery lesion. The second stage is the recanalization of
the femoral-popliteal segment with angioplasty and stent implantation in the affected area.
In the postoperative period, a loading dose of clopidogrel 300 mg + cardiomagnyl 75 mg is
taken. Next, the patient takes dual antiplatelet therapy cardiomagnyl 75 mg + clopidogrel 75
mg for 6 months.
Statistical analysis: Data processing and comparison of variables will be carried out by
appropriate statistical methods with a preliminary check for compliance of the sign
variability with the normal distribution, which is evaluated by the Kolmogorov-Smirnov
criterion. Under the condition of the normal distribution, Student's criterion is used. A
comparative assessment of qualitative characteristics is carried out using the χ2 criterion.
The dynamics of the indicators in the group will be determined by the pairwise coupled option
using the Student criterion with a normal distribution of indicators and using the Wilcoxon
criterion - with a mismatch with the normal distribution. Comparison according to qualitative
characteristics (gender, degree of ischemia, and others) will be carried out using the
criteria of Pearson (Pearson) and Fisher (Fisher). In all cases, a 95% significance level is
used.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03121430 -
Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion
|
N/A | |
Completed |
NCT01327950 -
Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions
|
N/A | |
Completed |
NCT05451485 -
VFI in Healthy Vessels
|
||
Not yet recruiting |
NCT04175197 -
LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
|
||
Withdrawn |
NCT05079906 -
Assessment of Superficial Femoral Artery Lesions With FFR From the ACIST Navvus® Catheter
|
N/A | |
Recruiting |
NCT04971772 -
SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries
|
||
Recruiting |
NCT04434586 -
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
|
N/A | |
Recruiting |
NCT05291247 -
Shockwave IVL + DES
|
||
Completed |
NCT01602159 -
Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST)
|
N/A | |
Not yet recruiting |
NCT06410313 -
First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
|
N/A | |
Terminated |
NCT00908947 -
CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")
|
N/A | |
Recruiting |
NCT05132361 -
SELUTION4SFA Trial
|
N/A | |
Completed |
NCT01336101 -
Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
|
N/A | |
Recruiting |
NCT06416644 -
The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
|
N/A |